Page 7 - 2021_02-Haematologica-web

532 Clinical significance of soluble CADM1 as a novel marker for adult T-cell leukemia/lymphoma Shingo Nakahata et al.
https://doi.org/10.3324/haematol.2019.234096
Chronic Lymphocytic Leukemia
543 Bendamustine followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia: primary endpoint analysis of a multicenter, open-label, phase II trial (CLL2-BIO)
Paula Cramer et al.
https://doi.org/10.3324/haematol.2019.223693
Myelodysplastic Syndromes
555 Genomic alterations in patients with somatic loss of the Y chromosome as the sole cytogenetic finding in bone marrow cells Madhu M. Ouseph et al.
https://doi.org/10.3324/haematol.2019.240689
Acute Myeloid Leukemia
565 Synergistic activity of IDH1 inhibitor BAY1436032 with azacitidine in IDH1 mutant acute myeloid leukemia Anuhar Chaturvedi et al.
https://doi.org/10.3324/haematol.2019.236992
Letters to the Editor
574 Novel L-nucleoside analog, 5-fluorotroxacitabine, displays potent efficacy against acute myeloid leukemia Aniket Bankar et al.
https://doi.org/10.3324/haematol.2019.226795
580 Wip1 regulates hematopoietic stem cell development in the mouse embryo Wenyan He et al.
https://doi.org/10.3324/haematol.2019.235481
585 CD4+ T-cell alloreactivity after haploidentical hematopoietic stem cell transplantation Burak Kalin et al.
https://doi.org/10.3324/haematol.2019.244152
589 Daratumumab inhibits acute myeloid leukemia metabolic capacity by blocking mitochondrial transfer from mesenchymal stromal cells Jayna J. Mistry et al.
https://doi.org/10.3324/haematol.2019.242974
593 Clinicopathological and genetic features of limited-stage diffuse large B-cell lymphoma with late relapse: targeted sequencing analysis of gene alterations in the initial and late relapsed tumors
Tomotaka Suzuki et al.
https://doi.org/10.3324/haematol.2019.235598
597 Primary therapy and survival in patients over 70 years old with primary central nervous system lymphoma: a contemporary, nationwide, population-based study in the Netherlands
Matthijs van der Meulen et al.
https://doi.org/10.3324/haematol.2020.247536
601 Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis
Zuzana Chyra et al.
https://doi.org/10.3324/haematol.2019.239756
haematologica Journal of the Ferrata Storti Foundation
Coagulation & its Disorders
522 uPA-mediated plasminogen activation is enhanced by polyphosphate Claire S. Whyte and Nicola J. Mutch
https://doi.org/10.3324/haematol.2019.237966
Acute Lymphoblastic Leukemia
Haematologica 2021; vol. 106 no. 2 - February 2021 http://www.haematologica.org/